News
Philip Morris International Inc. (PMI) Announces Concrete Steps to Scale Down Operations in the Russian Federation and Its Intention to Exit the Market
Regulatory News:
Further to its announcement released on March 9, 2022, Philip Morris International Inc. (NYSE: PM) today announces the concrete steps it has taken to suspend planned investments
State Street Collateral+ Platform Now Live with Pirum’s CollateralConnect Service
State Street Corporation (NYSE:STT) announced today the integration of its Collateral+ platform with Pirum’s CollateralConnect service to support mutual clients with collateral management and
Nordea Bank Abp: Nordea's Board of Directors has decided on payment of ordinary dividend in its statutory meeting
Farmers National Banc Corp. and Emclaire Financial Corp. Announce Merger
Farmers National Banc Corp. (“Farmers”) (NASDAQ: FMNB), the holding company for The Farmers National Bank of Canfield (“Farmers Bank”), and Emclaire Financial Corp. (“Emclaire”) (NASDAQ: EMCF), the
Lineage to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC on March 28, 2022
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M
PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”)
Biomind Labs to Commence Commercial Clinical Trial on Its Proprietary Mescaline Candidate BMND06
Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company developing the next generation of pharmaceuticals to treat patients suffering from
Viad Corp to Expand Pursuit’s Glacier Park Collection With Acquisition
Viad Corp (NYSE:VVI), a leading global provider of extraordinary experiences, including hospitality and leisure activities, experiential marketing, and live events, today announced that it has
Graham Corporation Announces Changes to Board of Directors
Graham Corporation (NYSE: GHM), a global business that designs, manufactures and sells critical equipment for the defense/space, energy/new energy and chemical/petrochemical industries, today
Nordea Bank Abp: Decisions of Nordea's Annual General Meeting 2022
Nordea Bank Abp: Nordea's Board of Directors resolved on a transfer of own shares pursuant to variable remuneration programmes
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Oragin Foods Appoints Food and Beverage Industry Executive Matthew Merson to Advisory Board to Support U.S. Expansion
Oragin Foods Inc. (“ORAGIN” or the “Company”) (TSXV: OG, OTCQX: OGGFF, FRA: 9CW) is pleased to announce the appointment of Mr. Matthew Merson to the Company’s Advisory Board to support the growth
DGAP-News: Biotest AG: Biotest exceeds sales guidance in fiscal year 2021
ABB shareholders approve all proposals at 2022 Annual General Meeting
The shareholders of ABB have approved all the proposals by the company’s Board of Directors at its 2022 Annual General Meeting. As ABB continues to prioritize the health of its shareholders and
Tokens.com Partners with Forever 21 for Metaverse Storefront
Tokens.com Corp. (NEO Exchange Canada: COIN) (Frankfurt Stock Exchange: 76M) (OTCQB US: SMURF) (“Tokens.com” or “the Company”), a publicly-traded company that invests in Web3 crypto assets and
Columbia Care Reports Record Fourth Quarter and Full Year 2021 Results; Issues 2022 Guidance Under U.S. GAAP
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today reported financial and operating results for the fourth quarter ended December 31
Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV in Older Adults
Pfizer Inc. (NYSE:PFE) today announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or RSVpreF, received Breakthrough Therapy Designation from the U.S. Food and Drug
DGAP-News: DIC Asset AG: Virtual Annual General Meeting 2022 approves dividend in the amount of EUR 0.75 per share
DGAP-Adhoc: Jungheinrich AG: Jungheinrich forecast for 2022 financial year below market expectations due to economic uncertainty
NICE Actimize Wins FinTech Breakthrough Award for Fraud Prevention Innovation with AI-Powered IFM-X Dark Web Intelligence and New Account Fraud Solutions
NICE Actimize, a NICE (Nasdaq: NICE) business today announced that its IFM-X Dark Web Intelligence and New Account Fraud solutions have been selected as winners of the “Fraud Prevention Innovation
DGAP-News: Stabilus S.A.: Extraordinary General Meeting resolves change of legal form from Société Anonyme (S.A.) to Societas Europaea (SE)
DGAP-News: Aareal Bank acquires payment solutions provider CollectAI from Otto Group
DGAP-Adhoc: Wacker Neuson SE: Executive Board and Supervisory Board propose dividend payout of EUR 0.90 per share